Unknown

Dataset Information

0

DAPT, a potent Notch inhibitor regresses actively growing abdominal aortic aneurysm via divergent pathways.


ABSTRACT: Abdominal aortic aneurysm (AAA) is a localized pathological dilation of the aorta exceeding the normal diameter (?20 mm) by more than 50% of its original size (?30 mm), accounting for approximately 150000-200000 deaths worldwide per year. We previously reported that Notch inhibition does not decrease the size of pre-established AAA at late stage of the disease. Here, we examined whether a potent pharmacologic inhibitor of Notch signaling (DAPT (N-[N-(3,5-Difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester)), regresses an actively growing AAA. In a mouse model of an aneurysm (Apoe-/- mice; n=44); DAPT (n=17) or vehicle (n=17) was randomly administered at day 14 of angiotensin II (AngII; 1 µg/min/kg), three times a week and mice were killed on day 42. Progressive increase in aortic stiffness and maximal intraluminal diameter (MILD) was observed in the AngII + vehicle group, which was significantly prevented by DAPT (P<0.01). The regression of aneurysm with DAPT was associated with reduced F4/80+Cd68+ (cluster of differentiation 68) inflammatory macrophages. DAPT improved structural integrity of aorta by reducing collagen fibrils abnormality and restoring their diameter. Mechanistically, C-C chemokine receptor type 7 (Ccr7)+F4/80- dendritic cells (DCs), implicated in the regression of aneurysm, were increased in the aorta of DAPT-treated mice. In the macrophages stimulated with AngII or lipopolysaccharide (LPS), DAPT reverted the expression of pro-inflammatory genes Il6 and Il12 back to baseline within 6 h compared with vehicle (P<0.05). DAPT also significantly increased the expression of anti-inflammatory genes, including c-Myc, Egr2, and Arg1 at 12-24 h in the LPS-stimulated macrophages (P<0.05). Overall, these regressive effects of Notch signaling inhibitor emphasize its therapeutic implications to prevent the progression of active AAAs.

SUBMITTER: Hans CP 

PROVIDER: S-EPMC7890598 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

DAPT, a potent Notch inhibitor regresses actively growing abdominal aortic aneurysm via divergent pathways.

Hans Chetan P CP   Sharma Neekun N   Dev Rishabh R   Blain Jones M JM   Tonniges Jeff J   Agarwal Gunjan G  

Clinical science (London, England : 1979) 20200601 12


Abdominal aortic aneurysm (AAA) is a localized pathological dilation of the aorta exceeding the normal diameter (∼20 mm) by more than 50% of its original size (≥30 mm), accounting for approximately 150000-200000 deaths worldwide per year. We previously reported that Notch inhibition does not decrease the size of pre-established AAA at late stage of the disease. Here, we examined whether a potent pharmacologic inhibitor of Notch signaling (DAPT (N-[N-(3,5-Difluorophenacetyl)-l-alanyl]-S-phenylgly  ...[more]

Similar Datasets

| S-EPMC6748927 | biostudies-literature
| S-EPMC3058859 | biostudies-literature
2023-05-25 | GSE232911 | GEO
2020-11-21 | GSE137577 | GEO
2007-07-26 | GSE7084 | GEO
2022-05-20 | PXD030441 | Pride
| S-EPMC8401627 | biostudies-literature
| S-EPMC10749584 | biostudies-literature
| S-EPMC5453572 | biostudies-literature
| S-EPMC6789891 | biostudies-literature